Clinical Trials Browser

Phase 1 × RO5126766 × Tumor-Agnostic × Clear all

NCT00773526 2016-11-02

A Dose-Escalation Study of RO5126766 in Patients With Advanced Solid Tumors.

Phase 1 Completed

Neoplasms